RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models

Image
book icon

Publication Details

location-icon

The Journal of Clinical Investigation

calander-icon

April 2020

Image
pen icon

Author(s)

Nadine Haase1 2 3 4 5, Donald J Foster6, Mark W Cunningham7, Julia Bercher3, Tuyen Nguyen6, Svetlana Shulga-Morskaya6, Stuart Milstein6, Sarfraz Shaikh6, Jeff Rollins6, Michaela Golic1 2 3 5, Florian Herse1 2 3 5, Kristin Kräker 1 2 3 4 5, Ivo Bendix8, Meray Serdar8, Hanna Napieczynska1, Arnd Heuser1, Alexandra Gellhaus9, Kristin Thiele10, Gerd Wallukat3, Dominik N Müller1 2 3 4 5, Babbette LaMarca7 11, Ralf Dechend1 2 3 5 12

1Max-Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany; 2Charité - Universitätsmedizin Berlin, Berlin Germany; 3Experimental and Clinical Research Center, Berlin, Germany; 4DZHK (German Centre for Cardiovascular Research), Berlin, Germany; 5Berlin Institute of Health (BIH), Berlin, Germany; 6Alnylam Pharmaceuticals, Cambridge, Massachusetts, USA; 7Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi, USA; 8Department of Pediatrics I Neonatology and Experimental Perinatal Neurosciences and; 9Department of Gynecology and Obstetrics, University Hospital Essen, University Duisburg-Essen, Essen, Germany; 10Department of Experimental Feto-Maternal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 11Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, Mississippi, USA; 12HELIOS-Klinikum, Berlin, Germany;

Image
abstract

PMID

32338644

Image
abstract

DOI

10.1172/JCI99417

Image
book

Publication Materials